BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20735434)

  • 1. let-7 and miR-17-92: small-sized major players in lung cancer development.
    Osada H; Takahashi T
    Cancer Sci; 2011 Jan; 102(1):9-17. PubMed ID: 20735434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in biological processes and carcinogenesis.
    Osada H; Takahashi T
    Carcinogenesis; 2007 Jan; 28(1):2-12. PubMed ID: 17028302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNA in human lung squamous cell carcinoma.
    Yang Y; Li X; Yang Q; Wang X; Zhou Y; Jiang T; Ma Q; Wang YJ
    Cancer Genet Cytogenet; 2010 Jul; 200(2):127-33. PubMed ID: 20620595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis.
    Navarro A; Marrades RM; Viñolas N; Quera A; Agustí C; Huerta A; Ramirez J; Torres A; Monzo M
    Oncology; 2009; 76(3):162-9. PubMed ID: 19209007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
    Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).
    Wong MY; Yu Y; Walsh WR; Yang JL
    Int J Oncol; 2011 May; 38(5):1189-95. PubMed ID: 21399872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.
    Tai MC; Kajino T; Nakatochi M; Arima C; Shimada Y; Suzuki M; Miyoshi H; Yatabe Y; Yanagisawa K; Takahashi T
    Carcinogenesis; 2015 Dec; 36(12):1464-73. PubMed ID: 26483346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
    Melkamu T; Zhang X; Tan J; Zeng Y; Kassie F
    Carcinogenesis; 2010 Feb; 31(2):252-8. PubMed ID: 19748927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B; Stresemann C; Kuner R; Mund C; Musch T; Meister M; Sültmann H; Lyko F
    Cancer Res; 2007 Feb; 67(4):1419-23. PubMed ID: 17308078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MicroRNAs in diagnosis and prognosis in lung cancer].
    Avila-Moreno F; Urrea F; Ortiz-Quintero B
    Rev Invest Clin; 2011; 63(5):516-35. PubMed ID: 22468482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
    Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals.
    Glazov EA; McWilliam S; Barris WC; Dalrymple BP
    Mol Biol Evol; 2008 May; 25(5):939-48. PubMed ID: 18281269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
    Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.